COVID-19 and community resilience
The theme group is led by SwedenBIO’s Vice Chair Lotta Ljungqvist, CEO of Testa Center. SwedenBIO is represented by Janet Hoogstraate, Valneva.
Precision medicine and ATMP
SwedenBIO is represented by Johan Hyllner, Head of Cell Therapy Department at AstraZeneca.
Health data
SwedenBIO is represented by Björn Arvidsson, Director of STUNS Life Science and chairman of SwedenBIO’s internal working group for Public Affairs.
Input and documents
Input to the R&I proposal input
Action plan from SwedenBIO, LIF and Swedish Medtech
Input on international brightness and attractiveness
Precision medicine input
